SEC Comment Letter for Anixa Biosciences Inc (ANIX) (CIK 0000715446) (ANIX) — Apr 3, 2017
Anixa Biosciences Inc (ANIX) (CIK 0000715446)
Date: April 3, 2017 · CIK: 0000715446 · Accession: 0000000000-17-011058
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-217060
Letter
Mail Stop 4561 April 3 , 2017 Robert A. Berman President and Chief Executive Officer ITUS Corporation 12100 Wilshire Boulevard, Suite 1275 Los Angeles, CA 90025 ITUS Corporation Registration Statement on Form S-3 Filed March 31 , 2017 File No. 333-217060
Dear Mr. Berman:
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rule 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contac t Ji Shin, Attorney -Advisor, at (202) 551 -3579 or me at (202) 551 -3453 with any other questions.
Sincerely,
/s/ Jan Woo
Show Raw Text
Mail Stop 4561 April 3 , 2017 Robert A. Berman President and Chief Executive Officer ITUS Corporation 12100 Wilshire Boulevard, Suite 1275 Los Angeles, CA 90025 ITUS Corporation Registration Statement on Form S-3 Filed March 31 , 2017 File No. 333-217060 Dear Mr. Berman: This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rule 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contac t Ji Shin, Attorney -Advisor, at (202) 551 -3579 or me at (202) 551 -3453 with any other questions. Sincerely, /s/ Jan Woo Jan Woo Legal Branch Chief Office of Information Technologies and Services cc: Barry I. Grossman, Esq. Ellenoff Grossman & Sch ole LLP